ResearcherChinese Academy of SciencesActive in the last 2 years
Fei He
Matched on ORCID iD 0000-0003-0542-2686; OpenAlex author ID A5100720385. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- A dual-target pectin-like polysaccharide LRP01B from Lamiophlomis rotata induces pancreatic cancer cell apoptosis in vitro and in vivo by causing mitochondrial… Co-author DOI 10.1016/j.ijbiomac.2025.147227↗
- Convergent Synthesis and Anti-Pancreatic Cancer Cell Growth Activity of a Highly Branched Heptadecasaccharide from Carthamus tinctorius. Co-author DOI 10.1002/anie.202202554↗
- The structure elucidation of novel arabinogalactan LRP1-S2 against pancreatic cancer cells growth in vitro and in vivo. Co-author DOI 10.1016/j.carbpol.2021.118172↗
- Isolation and structural characterization of a pectin from Lycium ruthenicum Murr and its anti-pancreatic ductal adenocarcinoma cell activity. First author DOI 10.1016/j.carbpol.2019.115104↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kan Ding · 4 shared papers, 2019–2025 · strength 0.68
- Paper A dual-target pectin-like polysaccharide LRP01B from Lamiophlomis rotata induces pancreatic cancer cell apoptosis in vi… DOI 10.1016/j.ijbiomac.2025.147227↗
- Paper Convergent Synthesis and Anti-Pancreatic Cancer Cell Growth Activity of a Highly Branched Heptadecasaccharide from Cart… DOI 10.1002/anie.202202554↗
- Paper The structure elucidation of novel arabinogalactan LRP1-S2 against pancreatic cancer cells growth in vitro and in vivo. DOI 10.1016/j.carbpol.2021.118172↗
- Jianhao Xie · 1 shared paper, 2025 · strength 0.25
- Chaoyu Hu · 1 shared paper, 2022 · strength 0.15
- Deqin Cai · 1 shared paper, 2022 · strength 0.15
- Xia Chen · 1 shared paper, 2021 · strength 0.15
- Chenghao Shao · 1 shared paper, 2021 · strength 0.15
- Shihai Zhang · 1 shared paper, 2019 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.